Karyopharm Therapeutics

KPTI

KPTI
Karyopharm Therapeutics  Stock Quote
$5.91 -$0.08 -1.3%
BATS BZX Real Time Price as of June 18, 2019, 4:30 p.m. View Interactive KPTI Charts

Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.

News & Analysis: Karyopharm Therapeutics

All

Market Moves

Earnings











Interactive Chart